Delivery Order SPE2DB24D2215-SPE2DB25FGTHX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.46 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count) with a ceiling value of $1,446.57. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal medical procurement, with performance based in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,075.08 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packages). This non-competitive, firm fixed-price delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and this...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.35 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,566.44 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and was competitively awarded. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,345.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTHXDelivery Order
The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Armodafinil 250 mg, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed from the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order draws from AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency and military healthcare systems worldwide. The company's demonstrated capability to fulfill federal medical supply requirements through open competition positions it as a key supplier within DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |